金河生物科技股份有限公司关于回购注销部分限制性股票减少注册资本暨通知债权人的公告

Group 1 - The company announced the repurchase and cancellation of 30,000 restricted stocks due to the death of one of the incentive plan participants, resulting in a reduction of the total share capital by 30,000 yuan [1][2] - The company held its first extraordinary shareholders' meeting of 2026 on January 16, 2026, where the proposal for the repurchase of restricted stocks was approved [7][16] - The shareholders' meeting had a total of 492 participants, representing 257,913,778 shares, which is 34.0340% of the total voting shares [14] Group 2 - The company notified creditors that they have 45 days from the announcement date to claim debts or request guarantees due to the capital reduction [2][5] - The meeting's voting process combined both on-site and online methods, ensuring compliance with legal regulations [12][20] - Legal opinions confirmed that the meeting's procedures and voting results were legitimate and compliant with relevant laws [20]